StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research report sent to investors on Wednesday morning. The brokerage issued a hold rating on the biotechnology company’s stock.
Calithera Biosciences Price Performance
NASDAQ:CALA opened at $0.00 on Wednesday. Calithera Biosciences has a fifty-two week low of $0.00 and a fifty-two week high of $0.12.
Calithera Biosciences Company Profile
See Also
- Five stocks we like better than Calithera Biosciences
- What Are Treasury Bonds?
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- How to Most Effectively Use the MarketBeat Earnings Screener
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- What is Short Interest? How to Use It
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
